125 related articles for article (PubMed ID: 17290104)
21. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
22. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
[TBL] [Abstract][Full Text] [Related]
24. Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.
Kanai M; Tong WM; Wang ZQ; Miwa M
Biochem Biophys Res Commun; 2007 Aug; 359(3):426-30. PubMed ID: 17553458
[TBL] [Abstract][Full Text] [Related]
25. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
Kauppinen TM; Swanson RA
Neuroscience; 2007 Apr; 145(4):1267-72. PubMed ID: 17084037
[TBL] [Abstract][Full Text] [Related]
26. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
27. The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients.
Onaran I; Tezcan G; Ozgönenel L; Cetin E; Ozdemir AT; Kanigür-Sultuybek G
Rheumatol Int; 2009 May; 29(7):797-800. PubMed ID: 19030862
[TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus: An Observational and Bidirectional Mendelian Randomization Study.
Cui NH; Yang JM; Liu X; Wang XB
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2516-2526. PubMed ID: 32757651
[TBL] [Abstract][Full Text] [Related]
29. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
Ma SL; Tang NL; Lam LC; Chiu HF
Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
[TBL] [Abstract][Full Text] [Related]
30. CD14 receptor polymorphism and Alzheimer's disease risk.
Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
[TBL] [Abstract][Full Text] [Related]
31. Interaction between prion protein and interleukin-1A genes increases early-onset Alzheimer's disease risk.
Combarros O; Llorca J; Sánchez-Juan P; Mateo I; Infante J; Rodríguez E; Sánchez-Quintana C; Berciano J
J Neurol; 2007 Jan; 254(1):115-7. PubMed ID: 17508146
[No Abstract] [Full Text] [Related]
32. Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease.
Hu JL; Li G; Zhou DX; Zou YX; Zhu ZS; Xu RX; Jiang XD; Zeng YJ
Cell Mol Neurobiol; 2009 Feb; 29(1):81-5. PubMed ID: 18709454
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribose)polymerase activity is reduced in circulating mononuclear cells from type 2 diabetic patients.
Tempera I; Cipriani R; Campagna G; Mancini P; Gatti A; Guidobaldi L; Pantellini F; Mandosi E; Sensi M; Quesada P; Mario UD; D'Erme M; Morano S
J Cell Physiol; 2005 Dec; 205(3):387-92. PubMed ID: 15895395
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
Ghosh U; Das N; Bhattacharyya NP
Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
[TBL] [Abstract][Full Text] [Related]
35. Allele, genotype, and composite genotype effects of IL-1A +4845 and IL-1B +3954 polymorphisms for chronic periodontitis in an Indian population.
Gayathri R; Saadi AV; Bhat KM; Bhat SG; Satyamoorthy K
Indian J Dent Res; 2011; 22(4):612. PubMed ID: 22124068
[TBL] [Abstract][Full Text] [Related]
36. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
37. Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Stewart J; McCarron P; Love S; Vinters HV; Ironside JW; Mann DM; Graham DI; Nicoll JA
Stroke; 2003 Oct; 34(10):e193-5. PubMed ID: 12947160
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
39. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.
Grimaldi LM; Casadei VM; Ferri C; Veglia F; Licastro F; Annoni G; Biunno I; De Bellis G; Sorbi S; Mariani C; Canal N; Griffin WS; Franceschi M
Ann Neurol; 2000 Mar; 47(3):361-5. PubMed ID: 10716256
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
